Induction of High Neutralizing Activity Against Both Omicron BA.2 and Omicron BA.1 by Coronavirus Disease 2019 Messenger RNA Booster Vaccination.

Tjan, Lidya Handayani; Furukawa, Koichi; Kurahashi, Yukiya; Sutandhio, Silvia; Nishimura, Mitsuhiro; Arii, Jun; Mori, Yasuko

Tjan, Lidya Handayani; Furukawa, Koichi; Kurahashi, Yukiya; Sutandhio, Silvia; Nishimura, Mitsuhiro; Arii, Jun; Mori, Yasuko.

Tjan LH; Division of Clinical Virology, Center for Infectious Diseases, Kobe University Graduate School of Medicine, Kobe, Japan.
Furukawa K; Division of Clinical Virology, Center for Infectious Diseases, Kobe University Graduate School of Medicine, Kobe, Japan.
Kurahashi Y; Division of Clinical Virology, Center for Infectious Diseases, Kobe University Graduate School of Medicine, Kobe, Japan.
Sutandhio S; Division of Clinical Virology, Center for Infectious Diseases, Kobe University Graduate School of Medicine, Kobe, Japan.
Nishimura M; Division of Clinical Virology, Center for Infectious Diseases, Kobe University Graduate School of Medicine, Kobe, Japan.
Arii J; Division of Clinical Virology, Center for Infectious Diseases, Kobe University Graduate School of Medicine, Kobe, Japan.
Mori Y; Division of Clinical Virology, Center for Infectious Diseases, Kobe University Graduate School of Medicine, Kobe, Japan.

J Infect Dis ; 226(8): 1481-1483, 2022 10 17.

Article in English | MEDLINE | ID: covidwho-1886446

Subject(s)

COVID-19; COVID-19/prevention & control; Humans; Immunization, Secondary; RNA, Messenger; Vaccination

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Topics: Vaccines / Variants Limits: Humans Language: English Journal: J Infect Dis Year: 2022 Document Type: Article Affiliation country: Infdis

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google